Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: A retrospective analysis of prescription claims

American Journal of Therapeutics

Volumn 12, Issue 6, 2005, Pages 605-611

  McLaughlin, Trent ^a   Harnett, James ^b   Burhani, Soraya ^a   Scott, Brian ^a  

^a Wolters Kluwer   (United States)

^b PFIZER INC   (United States)

Author keywords

Adherence; Erectile dysfunction; Medication possession ratio; Sildenafil

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ORAL ANTIDIABETIC AGENT; SILDENAFIL;

ADULT; AGED; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; ERECTILE DYSFUNCTION; HEALTH CARE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; COMORBIDITY; DATABASES, FACTUAL; HUMANS; HYPOGLYCEMIC AGENTS; IMPOTENCE; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RETROSPECTIVE STUDIES; TREATMENT REFUSAL;

EID: 28044467941     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000181305.44330.4a     Document Type: Conference Paper

References (37)

1. Rosen RC, Fisher WA, Eardley I, et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004;20:607-617.
2. Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol. 2004;171:2341-2345.
3. Johannes CB, Araujo AB, Feldman HA, et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163:460-463.
4. Giuliano FA, Leriche A, Jaudinot EO, et al. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology. 2004;64:1196-1201.
5. Ponholzer A, Temml C, Mock K, et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005;47:80-86.
6. Seidman SN. The aging male: androgens, erectile dysfunction, and depression. J Clin Psychiatry. 2003;64(suppl 10):31-37.
7. Kloner RA, Mullin SH, Shook T, et al. Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol. 2003;170:S46-S50.
8. De Berardis G, Franciosi M, Belfiglio M, et al. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care. 2002;25:284-291.
9. Fogari R, Zoppi A. Effect of antihypertensive agents on quality of life in the elderly. Drugs Aging. 2004;21:377-393.
10. Rosen RC, Marin H. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry. 2003;64(suppl 10):5-10.
11. Roose SP. Depression: links with ischemic heart disease and erectile dysfunction. J Clin Psychiatry. 2003;64(suppl 10):26-30.
12. Labbate LA, Croft HA, Oleshansky MA. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry. 2003;64(suppl 10):11-19.
13. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999;19:67-85.
14. Rizvi K, Hampson J, Harvey J. Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Fam Pract. 2002;19:95-98.
15. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61.
16. Keene LC, Davies PH. Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev. 1999;18:5-24.
17. Perez-Stable EJ, Halliday R, Gardiner PS, et al. The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. Am J Med. 2000;108:359-365.
18. Lowentritt BH, Sklar GN. The effect of erectile dysfunction on patient medication compliance. [abstract] J Urol. 2004;171:231.
19. Nunes MI. The relationship between quality of life and adherence to treatment. Curr Hypertens Rep. 2001;3:462-465.
20. Svensson S, Kjellgren KI, Ahlner J, et al. Reasons for adherence with antihypertensive medication. Int J Cardiol. 2000;76:157-163.
21. Schulberg HC, Katon W, Simon GE, et al. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry. 1998;55:1121-1127.
22. Nurnberg HG, Hensley PL. Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction: a review of diagnosis, treatment, and relevance. CNS Spectr. 2003;8:194-202.
23. Nurnberg HG, Hensley PL. Sildenafil citrate for the management of antidepressant-associated erectile dysfunction. J Clin Psychiatry. 2003;64(suppl 10):20-25.
24. Nurnberg HG, Hensley PL, Gelenberg AJ, et al. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA. 2003;289:56-64.
25. Nurnberg HG, Duttagupta S. Economic analysis of sildenafil citrate (Viagra®) add-on to treat erectile dysfunction associated with selective serotonin reuptake inhibitor use. Am J Ther. 2004;11:9-12.
26. Elliott WJ. Optimizing medication adherence in older persons with hypertension. Int Urol Nephrol. 2003;35:557-562.
27. Hoffman L, Enders J, Luo J, et al. Impact of an antidepressant management program on medication adherence. Am J Manag Care. 2003;9:70-80.
28. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27:2149-2153.
29. Parris ES, Lawrence DB, Mohn LA, et al. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005;28:595-599.
30. Skaer TL, Sclar DA, Markowski DJ, et al. Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension. J Hum Hypertens. 1993;7:515-518.
31. Skaer TL, Sclar DA, Markowski DJ, et al. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures - a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther. 1993;18:295-299.
32. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116.
33. Duttagupta S, Wade S, Batra D, et al. Improved compliance of concomitant medications after Viagra (sildenafil citrate) treatment. Presented at the 4th Biennial Congress of the European Society for Sexual and Impotence Research, Sep 3-Oct 3, Rome, Italy. 2001.
34. Tignol J, Furlan PM, Gomez-Beneyto M, et al. Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression. Int Clin Psychopharmacol. 2004;19:191-199.
35. Cappelleri J, Duttagupta S, Sherman N, et al. Self-esteem, confidence, and relationships in men with erectile dysfunction treated with sildenafil citrate. I Gen Intern Med. 2004;19(suppl 1):209.
36. Altrof SE, Cappelleri JC, Shpilsky A, et al. Treatment responsiveness of the Self-Esteem and Relationship questionnaire in erectile dysfunction. Urology. 2003;61:888.
37. Marwick C. Survey says patients expect little physician help on sex. JAMA. 1999;281:2173-2174.